The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats
- 31 March 2001
- journal article
- Published by Elsevier BV in Pharmacological Research
- Vol. 43 (3), 211-218
- https://doi.org/10.1006/phrs.2000.0769
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat cardiomyocytesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1999
- Glutamine Protects against Doxorubicin-Induced CardiotoxicityJournal of Surgical Research, 1999
- L-carnitine attenuates doxorubicin-induced lipid peroxidation in ratsFree Radical Biology & Medicine, 1999
- Adriamycin-induced changes of creatine kinase activity in vivo and in cardiomyocyte cultureToxicology, 1999
- Induction of Antioxidants by Adriamycin in Mouse HeartBiochemical Pharmacology, 1998
- Role of iron in the potentiation of anthracycline cardiotoxicity: Identification of heart cell mitochondria as a major site of iron-anthracycline interactionJournal of Laboratory and Clinical Medicine, 1996
- Prevention of Anthracycline Cardiotoxicity by Iron ChelationActa Haematologica, 1996
- The Role of Iron and Iron Chelators in Anthracycline CardiotoxicityLeukemia & Lymphoma, 1993
- Anthracycline Cardiotoxicity: In vivo and in vitro Effects on Biochemical Parameters and Heart Ultrastructure of the RatOncology, 1991
- Release of iron from ferritin by cardiotoxic anthracycline antibioticsArchives of Biochemistry and Biophysics, 1986